Plymouth-based renewable chemistry company BioAmber Inc. said it secured $45 million in venture capital financing.
The company said part of the money will go toward building a large-scale plant in North America and speeding the commercialization of some of its products. It will also help fund research and development in other areas, BioAmber said.
The financing round was co-led by European investment fund NAXOS Capital Partners and Paris-based venture capital firm Sofinnova Partners. Other investors in the round were Mitsui & Co. Venture Partners, Tokyo-based trading company Mitsui & Co. and Cliffton Group in Quebec.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Star Tribune
Local
What to know about the latest COVID variants, Minnesota testing, vaccines
Expert advice on masking, testing, vaccines and boosters is evolving along with coronavirus variants. Here's the latest from Minnesota and the CDC.
Sign up for Star Tribune newsletters
Subscribe to Star Tribune newsletters, including Essential Minnesota, breaking news and Hot Dish.
Drone footage shows Ukrainian village battered to ruins as residents flee Russian advance
The Ukrainian village of Ocheretyne has been battered by fighting, drone footage shows. The village has been a target for Russian forces in Donetsk.
Election
In heated western Minn. GOP congressional primary, outsiders challenging incumbent
U.S. Rep. Michelle Fischbach has a solidly conservative voting record. But Steve Boyd, a Christian conservative who has never held public office, is gaining traction as an outsider.
